TITLE

Comparison of the Effects of Letrozole and Clomiphene Citrate on Ovulation and Pregnancy Rate in Patients with Polycystic Ovary Syndrome

AUTHOR(S)
Dehbashi, Sedigheh; Dehbashi, Sara; Kazerooni, Talieh; Robati, Minoo; Alborzi, Saeed; Parsanezhad, Mohammad Ebrahim; Shadman, Arash
PUB. DATE
March 2009
SOURCE
Iranian Journal of Medical Sciences;Mar2009, Vol. 34 Issue 1, p23
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: For more than four decades clomiphene citrate has been the first line of the treatment for ovulatory disorders. The aim of this study was to compare the effects of letrozole and clomiphene citrate on ovulation and pregnancy rate in patients with polycystic ovary syndrome. Methods: In this prospective double-blind study, 100 patients with polycystic ovary syndrome were randomized into two equal groups. The first group received letrozole, 5mg daily (per oral) and the second group received clomiphene, 100mg daily during the 3rd-7th days of the menstrual cycles. Intramuscular human chorionic gonadotropin (hCG) (10,000 IU) was administered to trigger ovulation when at least one mature follicle (≥ 18mm) was developed. Results: Ovulation occurred in 30 patients (60%) of the letrozole group and in 16 patients (32%) of the clomiphene group, which showed a statistically significant difference (P=0.009). The mean number of follicles with diameter >14 mm on the day of administration of hCG was 1.06±0.95 in the letrozole group and 1.14±1.17 in the clomiphene group, which showed non-significant difference (P=0.962). No difference was found in the endometrial thickness between the two groups. A non-significant increase in pregnancy rate was observed in the letrozole group (26% v 14% P=0.21). Conclusion: Ovulation rate was higher in letrozole group and administration of letrozole was associated with a nonsignificant increase in pregnancy rate.
ACCESSION #
46815623

 

Related Articles

  • Luteal phase clomiphene citrate for ovulation induction in women with polycystic ovary syndrome. Kosar, Ozlem; Ozaksit, Gulnur; Taskin, Mine // Archives of Gynecology & Obstetrics;Oct2014, Vol. 290 Issue 4, p771 

    Purpose: The aim was to test a new protocol of luteal phase administration of clomiphene citrate (CC) for ovulation induction in women with polycystic ovary syndrome (PCOS). Methods: This was a prospective, randomized, controlled trial. Two hundred and fifty-two women (cycles) with PCOS were...

  • Clomiphene citrate or letrozole as first-line ovulation induction drug in infertile PCOS women: A prospective randomized trial. Kar, Sujata // Journal of Human Reproductive Sciences;Sep-Dec2012, Vol. 5 Issue 3, p262 

    OBJECTIVE: To compare Letrozole (5 mg) and clomiphene citrate (100 mg) as first line ovulation induction drug in infertile PCOS women. STUDY DESIGN: Prospective Randomised trial. SETTING: A Tertiary level infertility centre. Patients: 103 infertile PCOS women INTERVENTION(S): Treatment naïve...

  • Modified Technique Using Monopolar Hook Electrode Produces Good Results. Ott, Johannes // Fertility Weekly;11/21/2011, p4 

    The article discusses the study titled "A Modified Technique of Laparoscopic Ovarian Drilling for Polycystic Ovary Syndrome Using the Monopolar Hook Electrode," by Johannes Ott and colleagues. It states that the study involved 38 clomiphene-resistant with polycystic ovary syndrome (PCOS)...

  • Combining Metformin and Clomiphene Citrate may Yield Better Results than Monotherapy.  // Fertility Weekly;2/3/2014, p9 

    The article focuses on the study by Xiaoli Sun and colleagues which examines the effect of combining metformin (MET) and clomiphene citrate (CC) in the ovulation and reproductive outcomes in women with polycystic ovary syndrome (PCOS). The study is investigated by meta-analysis of data from...

  • Metformin is a Suitable First-line Treatment Option in Non-obese Women.  // Fertility Weekly;9/12/2011, p3 

    The article discusses the study by researcher Neil Johnson from New Zealand on the efficacy of metformin in the ovulation induction of non-obese women with anovulatory polycystic ovary syndrome (PCOS). Johnson uses Medline to perform a meta-analysis of randomized controlled trials which compares...

  • Gene expression profiling of granulosa cells from PCOS patients following varying doses of human chorionic gonadotropin. Coskun, Serdar; Otu, Hasan; Awartani, Khalid; Al-Alwan, Laila; Al-Hassan, Saad; Al-Mayman, Hend; Kaya, Namik; Inan, Mehmet // Journal of Assisted Reproduction & Genetics;Mar2013, Vol. 30 Issue 3, p341 

    Purpose: Human chorionic gonadotrophin (hCG) has been used to induce ovulation and oocyte maturation. Although the most common dose of hCG used in IVF is 10,000 IU, there are reports that suggest 5,000 IU is sufficient to yield similar results. The objective of this study is to evaluate the dose...

  • Surrogate end-points or primary outcomes in clinical trials in women with polycystic ovary syndrome? Richard S. Legro; Evan Myers // Human Reproduction;Aug2004, Vol. 19 Issue 8, p1697 

    There are multiple surrogate variables in polycystic ovary syndrome (PCOS), including biometric and biochemical parameters. The number of surrogate variables and their poor validity in relationship to primary clinical end-points pose major problems to conducting a trial in women with PCOS. The...

  • Ovulation induction using laparoscopic ovarian drilling in women with polycystic ovarian syndrome: predictors of success. S.A.K. Amer; T.C. Li; W.L. Ledger // Human Reproduction;Aug2004, Vol. 19 Issue 8, p1719 

    BACKGROUND: Although laparoscopic ovarian drilling (LOD) has been widely used to induce ovulation in women with polycystic ovarian syndrome (PCOS), predicting the clinical response to this treatment remains to be elucidated further. This study was carried out to identify factors that may help to...

  • Clomiphene Citrate Produces Higher Ovulation Rates than Metformin.  // Fertility Weekly;12/13/2010, p9 

    The article presents a study conducted by state researchers in Turkey on the higher rate of ovulation of clomiphene citrate than the insulin-sensitizing drug metformin in anovulatory polycystic ovary syndrome (PCOS) patients. The study found that PCOS is the most common cause of anovulatory...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics